论文部分内容阅读
AIM:To investigate the relationship between CD14-260and-651 polymorphisms and the risk of developing gastric cancer.METHODS:DNA was extracted from peripheral blood samples obtained from 225 Tibetans with gastric cancer and 237 healthy Tibetans,and analyzed using the polymerase chain reaction/ligase detection(PCR/LDR)method to determine the genotypes at-260 and-651loci of the CD14 promoter.The allele frequencies,genotype frequencies,and haplotypes were analyzed for their association with gastric cancer risk using online SHEsis software.The luciferase reporter assay and point mutation analysis were used to construct in vitro plasmids expressing a C/T homozygote at the-260 lo-cus of the CD14 promoter.RESULTS:The frequencies of CC,CT and TT genotypes in the CD14-260 C/T locus in gastric cancer patients were 19.1%,38.7%and 42.2%,respectively,whereas they were 33.3%,32.5%and 34.2%,respectively,in healthy control subjects.CT genotype carriers were more frequently found among gastric cancer patients than healthy controls(OR=2.076;95%CI:1.282-3.360).Also,TT genotype carriers were more frequently found among gastric cancer patients(OR=2.155;95%CI:1.340-3.466).Compared to the C allele of CD14/-260,the T allele was associated with an increased risk for gastric cancer(OR=1.574;95%CI:1.121-2.045).Furthermore,the frequencies of CC,CT and TT in the CD14-651 C/T locus in gastric cancer patients were 64.4%,29.3%and 6.2%,respectively,while they were 56.5%,35.0%and 8.4%,respectively,in the healthy control subjects(P>0.05).Data obtained using the luciferase reporter assay showed that the p260T homozygote was associated with greater CD14 promoter activity(P<0.01).CONCLUSION:CD14/-260 polymorphism is associated with gastric cancer risk in Highland Tibetans and affects CD14 promoter activity,thereby regulating CD14expression.
AIM: To investigate the relationship between CD14-260 and-651 polymorphisms and the risk of developing gastric cancer. METHODS: DNA was extracted from peripheral blood samples obtained from 225 Tibetans with gastric cancer and 237 healthy Tibetans, and analyzed using the polymerase chain reaction / ligase detection (PCR / LDR) method to determine the genotypes at-260 and-651loci of the CD14 promoter.The allele frequencies, genotype frequencies, and haplotypes were analyzed for their association with gastric cancer risk using online SHEsis software. luciferase reporter assay and point mutation analysis were used to construct in vitro plasmids expressing a C / T homozygote at the-260 lo-cus of the CD14 promoter .RESULTS: The frequencies of CC, CT and TT genotypes in the CD14-260 C / T locus in gastric cancer patients were 19.1%, 38.7% and 42.2% respectively, respectively, they were 33.3%, 32.5% and 34.2%, respectively, in healthy control subjects. Tients than healthy controls (OR = 2.076; 95% CI: 1.282-3.360). Also, TT genotype carriers were more frequently found among gastric cancer patients (OR = 2.155; 95% CI: 1.340-3.466). Compared to the C allele of CD14 / -260, the T allele was associated with an increased risk for gastric cancer (OR = 1.574; 95% CI: 1.121-2.045) .Furthermore, the frequencies of CC, CT and TT in the CD14-651 C / T respectively, while they were 56.5%, 35.0% and 8.4% respectively, in the healthy control subjects (P> 0.05). Data obtained using the luciferase reporter assay assay showed that the p260T homozygote was associated with greater CD14 promoter activity (P <0.01) .CONCLUSION: CD14 / -260 polymorphism is associated with gastric cancer risk in Highland Tibetans and affects CD14 promoter activity, thereby regulating CD14 expression.